CS logo
small CS logo
ZorgSaam

Terneuzen, Netherlands
Ziekenhuis in Terneuzen

About ZorgSaam


ZorgSaam Ziekenhuis is een onderdeel van de ZorgSaam Zorggroep Zeeuws-Vlaanderen. Het is een ziekenhuis met drie locaties in de regio Zeeuws-Vlaanderen. Locatie De Honte in de Nederlandse stad Terneuzen is de grootste locatie.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at ZorgSaam


During the past decade, ZorgSaam conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "ZorgSaam" #1 collaborator was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Admiraal de Ruyter Hospital" with 1 trials as a collaborator, "Alrijne Hospital" with 1 trials as a collaborator, "Amphia Hospital" with 1 trials as a collaborator and "BOOG Study Center" with 1 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

Clinical Trials Conditions at ZorgSaam


According to Clinical.Site data, the most researched conditions in "ZorgSaam" are "Breast Cancer" (1 trials), "Breast Neoplasm Female" (1 trials), "CLL" (1 trials), "Colorectal Cancer" (1 trials) and "Family Caregivers" (1 trials). Many other conditions were trialed in "ZorgSaam" in a lesser frequency.

Clinical Trials Intervention Types at ZorgSaam


Most popular intervention types in "ZorgSaam" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials), "CDK 4/6 inhibitor" (1 trials) and "Fulvestrant" (1 trials). Other intervention names were less common.

Clinical Trials Genders at ZorgSaam


The vast majority of trials in "ZorgSaam" are 6 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at ZorgSaam


Currently, there are NaN active trials in "ZorgSaam". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in ZorgSaam, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in ZorgSaam, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".